PAULA (Policy-Augmented Utilization Logic Agent) is a physician-led AI platform that turns complex payer policies, CMS updates, and state AI regulations into structured operational intelligence for hospital utilization review teams, physician advisors, and revenue cycle leaders.

How does PAULA help reduce claim denials?

PAULA decomposes payer rules, CMS updates, and reimbursement shifts into structured logic cards and denial-risk signals, helping UR teams identify recoverable assets, cite applicable state laws in appeals, and act on regulatory changes before competitors.

What types of healthcare organizations use PAULA?

PAULA is designed for hospital utilization review directors, physician advisors, CFOs, compliance officers, and risk executives at health systems of all sizes seeking to protect revenue and navigate AI governance requirements.

How does PAULA track state AI legislation?

PAULA monitors 240+ state AI bills across 43 states in real time, surfacing jurisdiction-specific rules that create legal grounds to challenge AI-generated payer denials and converting them into Monday-morning action items for UR teams.

Is PAULA affiliated with any payer organization?

No. PAULA has zero payer affiliation. It was built by a physician who worked on both sides of the utilization review process and decided the conflict of interest was a problem worth solving.

What is the OIG investigation PAULA helps with?

PAULA surfaces federal enforcement signals like OIG investigation OEI-09-24-00332, which examines Medicare Advantage post-acute denial rates, and translates them into operational playbooks for recovering previously unappealed denials.

How does PAULA support AI governance and compliance?

PAULA provides audit trail support including decision logs, version control, escalation records, clinician review pathways, and documentation of AI output generation — essential for explainability under evolving federal and state AI regulations.

What briefings does PAULA provide?

PAULA delivers role-specific policy intelligence briefings covering prior authorization rules, CMS updates, state AI legislation, Medicare Advantage compliance, and denial recovery opportunities — tailored for Physician Advisors, UM leaders, CFOs, and Compliance teams.

How is PAULA different from other utilization review tools?

Unlike payer-affiliated UM tools, PAULA was built by a physician with no payer conflict of interest, combining real-time regulatory tracking with structured clinical intelligence to give providers a level playing field in the denial management process.

How do I get started with PAULA?

You can assess your denial exposure and request a demo directly at paula.clinefficiency.pro by clicking the Assess Your Exposure button, or contact the team to schedule a consultation.

← BACK TO RESOURCES

PAULA™ REPORT 005 · JULY 2026PAYER INTELLIGENCE

The Number Everyone Is Talking About

UnitedHealth Group posted $5.5 billion in net profit for Q2 2026.

UNLOCK PAULA™ REPORT 005

Tell us who you are. We'll unlock the full report instantly.

Free to read. Physician-authored. Vendor-neutral. No payer affiliation. We use this to send you the next PAULA report — unsubscribe in one click.